全球醫藥物流市場規模、佔有率、趨勢及成長分析報告（2026-2034）

預計醫藥物流市場將從 2025 年的 1,089.5 億美元成長到 2034 年的 1,907.4 億美元，2026 年至 2034 年的複合年成長率為 6.42%。

由於對高效能藥品運輸和儲存的需求不斷成長，全球醫藥物流市場正顯著擴張。醫藥物流涉及藥品、疫苗和醫療用品的配送管理，同時嚴格控制品管和溫度。全球醫藥貿易的擴張進一步凸顯了可靠物流系統的重要性。

市場成長主要受藥品生產規模擴大和對溫控供應鏈需求增加的驅動。許多藥品，特別是生物製藥和疫苗，需要專門的低溫運輸物流來維持其療效。物流供應商正在投資先進的追蹤系統和溫度監控技術，以確保敏感醫療產品的安全運輸。

隨著全球醫療保健需求持續成長，醫藥物流市場前景依然強勁。先進低溫運輸技術和數位化供應鏈管理系統的發展可望提升效率和透明度。新興市場藥品出口的成長和醫療基礎設施的擴建預計將為物流供應商創造新的商機。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球醫藥物流市場：依供應類型分類

• 市場分析、洞察與預測
• 低溫運輸
• 非低溫運輸

第5章：全球醫藥物流市場：依服務類型分類

• 市場分析、洞察與預測
• 運輸
• 貯存
• 監視

第6章 全球醫藥物流市場：依運輸方式分類

• 市場分析、洞察與預測
• 航空
• 海
• 路
• 鐵路

第7章 全球醫藥物流市場：依應用領域分類

• 市場分析、洞察與預測
• 生物製藥
• 化學製藥
• 專業製藥

第8章 全球醫藥物流市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • CH Robinson
  • CEVA Logistics
  • DB Schenker
  • DHL Group
  • DSV A/S
  • FedEx Corporation
  • Kuehne+Nagel International AG
  • AP Moller "" Maersk
  • Nippon Express Holdings Inc
  • United Parcel Service（UPS）

The Pharmaceutical Logistics Market size is expected to reach USD 190.74 Billion in 2034 from USD 108.95 Billion (2025) growing at a CAGR of 6.42% during 2026-2034.

The global pharmaceutical logistics market has grown significantly due to increasing demand for efficient transportation and storage of pharmaceutical products. Pharmaceutical logistics involves managing the distribution of medicines, vaccines, and medical supplies while maintaining strict quality and temperature control. The rise in global pharmaceutical trade has strengthened the importance of reliable logistics systems.

Market growth is driven by expanding pharmaceutical production and the increasing need for temperature-controlled supply chains. Many medicines, especially biologics and vaccines, require specialized cold chain logistics to maintain product effectiveness. Logistics providers are investing in advanced tracking systems and temperature monitoring technologies to ensure safe delivery of sensitive medical products.

The future outlook for the pharmaceutical logistics market remains strong as global healthcare demand continues to rise. The development of advanced cold chain technologies and digital supply chain management systems may improve efficiency and transparency. Growing pharmaceutical exports and expanding healthcare infrastructure in emerging markets are expected to create new opportunities for logistics providers.

MARKET SEGMENTATION

By Offering

• Cold Chain
• Non-Cold Chain

By Service

• Transportation
• Storage
• Monitoring

By Mode of Transportation

• Air
• Sea
• Road
• Rail

By Application

• Biopharma
• Chemical Pharma
• Specialty Pharma

COMPANIES PROFILED

• CH Robinson, CEVA Logistics, DB Schenker, DHL Group, DSV AS, FedEx Corporation, Kuehne Nagel International AG, AP Moller Maersk, Nippon Express Holdings Inc, United Parcel Service UPS
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL PHARMACEUTICAL LOGISTICS MARKET: BY OFFERING 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Offering
• 4.2. Cold Chain Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Non-Cold Chain Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PHARMACEUTICAL LOGISTICS MARKET: BY SERVICE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Service
• 5.2. Transportation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Storage Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Monitoring Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PHARMACEUTICAL LOGISTICS MARKET: BY MODE OF TRANSPORTATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Mode Of Transportation
• 6.2. Air Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Sea Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Road Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Rail Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PHARMACEUTICAL LOGISTICS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Application
• 7.2. Biopharma Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Chemical Pharma Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Specialty Pharma Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL PHARMACEUTICAL LOGISTICS MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Offering
  • 8.2.2 By Service
  • 8.2.3 By Mode Of Transportation
  • 8.2.4 By Application
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Offering
  • 8.3.2 By Service
  • 8.3.3 By Mode Of Transportation
  • 8.3.4 By Application
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Offering
  • 8.4.2 By Service
  • 8.4.3 By Mode Of Transportation
  • 8.4.4 By Application
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Offering
  • 8.5.2 By Service
  • 8.5.3 By Mode Of Transportation
  • 8.5.4 By Application
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Offering
  • 8.6.2 By Service
  • 8.6.3 By Mode Of Transportation
  • 8.6.4 By Application
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL PHARMACEUTICAL LOGISTICS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 C.H. Robinson
  • 10.2.2 CEVA Logistics
  • 10.2.3 DB Schenker
  • 10.2.4 DHL Group
  • 10.2.5 DSV A/S
  • 10.2.6 FedEx Corporation
  • 10.2.7 Kuehne + Nagel International AG
  • 10.2.8 A.P. Moller "" Maersk
  • 10.2.9 Nippon Express Holdings Inc
  • 10.2.10 United Parcel Service (UPS)